Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

2.

Regulation of prescription drug promotion: direct-to-consumer advertising.

Baylor-Henry M, Drezin NA.

Clin Ther. 1998;20 Suppl C:C86-95. Review.

PMID:
9915094
3.
4.
5.

What nurse practitioners should know about direct-to-consumer advertising of prescription medications.

Viale PH.

J Am Acad Nurse Pract. 2003 Jul;15(7):297-304. Review.

PMID:
12929250
6.

Direct-to-consumer prescription drug advertising: trends, impact, and implications.

Wilkes MS, Bell RA, Kravitz RL.

Health Aff (Millwood). 2000 Mar-Apr;19(2):110-28. Review.

7.

Direct-to-consumer prescription drug advertising.

Terzian TV.

Am J Law Med. 1999;25(1):149-67. Review. No abstract available.

PMID:
10207573
8.

Direct-to-consumer promotion: an industry perspective.

Pines WL.

Clin Ther. 1998;20 Suppl C:C96-103. Review.

PMID:
9915095
9.

The impact of direct-to-consumer advertised drugs on drug sales in the US and New Zealand.

Norey E, Simone TM, Mousa SA.

Appl Health Econ Health Policy. 2008;6(2-3):93-102. doi: 10.2165/00148365-200806020-00002. Review.

PMID:
19231903
10.

Benefits and harms of direct to consumer advertising: a systematic review.

Gilbody S, Wilson P, Watt I.

Qual Saf Health Care. 2005 Aug;14(4):246-50. Review.

11.
12.

Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising.

West SL, Squiers LB, McCormack L, Southwell BG, Brouwer ES, Ashok M, Lux L, Boudewyns V, O'Donoghue A, Sullivan HW.

Pharmacoepidemiol Drug Saf. 2013 May;22(5):447-58. doi: 10.1002/pds.3416. Epub 2013 Feb 26. Review.

PMID:
23440924
13.

Direct-to-consumer advertising of pharmaceuticals.

Gellad ZF, Lyles KW.

Am J Med. 2007 Jun;120(6):475-80. Review.

14.

Effects of written drug information on patient knowledge and compliance: a literature review.

Morris LA, Halperin JA.

Am J Public Health. 1979 Jan;69(1):47-52. Review.

15.

State of the art in benefit-risk analysis: consumer perception.

Ueland Ø, Gunnlaugsdottir H, Holm F, Kalogeras N, Leino O, Luteijn JM, Magnússon SH, Odekerken G, Pohjola MV, Tijhuis MJ, Tuomisto JT, White BC, Verhagen H.

Food Chem Toxicol. 2012 Jan;50(1):67-76. doi: 10.1016/j.fct.2011.06.006. Epub 2011 Jun 12. Review.

PMID:
21683114
16.

Consumers' views of direct-to-consumer genetic information.

McBride CM, Wade CH, Kaphingst KA.

Annu Rev Genomics Hum Genet. 2010;11:427-46. doi: 10.1146/annurev-genom-082509-141604. Review.

PMID:
20690815
17.

Communication of medical product risk: how effective is effective enough?

Goldman SA.

Drug Saf. 2004;27(8):519-34. Review.

PMID:
15154825
18.

Nutrition communication: consumer perceptions and predicting intentions.

Dean M, Lähteenmäki L, Shepherd R.

Proc Nutr Soc. 2011 Feb;70(1):19-25. doi: 10.1017/S0029665110003964. Review.

PMID:
21266092
19.

Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm?

Mintzes B.

Annu Rev Public Health. 2012 Apr;33:259-77. doi: 10.1146/annurev-publhealth-031811-124540. Review.

PMID:
22429162
20.

Realities of drug use in society.

Lowy FH.

Drug Saf. 1990;5 Suppl 1:155-9. Review.

PMID:
2182059
Items per page

Supplemental Content

Write to the Help Desk